Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acaroid immunotherapy in allergic bronchial asthma
NCT00263640Phase 3Completed
- Sponsor
- Allergopharma
- Start
- May 2005
- Primary completion
- Apr 2009
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 3 trial of Acaroid in asthma, allergic rhinitis (AR), Rhinoconjunctivitis (RC), sponsored by Allergopharma. Started May 2005; status: completed.
02
Drugs
Acaroid
03
Conditions
asthmaallergic rhinitis (AR)Rhinoconjunctivitis (RC)
Beyond the preview
Go deeper on NCT00263640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00263640.